Catinazzo Thomas: insider trades.
Catinazzo Thomas reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.0M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Catinazzo Thomas
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | Officer · Chief Financial Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Relay Therapeutics, Inc. | S | 17,717 | $18.94 | 122,851 | Form 4 |
| 2026-08-14 | Relay Therapeutics, Inc. | S | 17,717 | $19.74 | 140,568 | Form 4 |
| 2026-07-28 | Relay Therapeutics, Inc. | S | 1,459 | $18.61 | 158,285 | Form 4 |
| 2026-07-06 | Relay Therapeutics, Inc. | S | 17,717 | $18.69 | 159,744 | Form 4 |
Questions
What stock did Catinazzo Thomas buy or sell?
Catinazzo Thomas reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.0M), across 1 company.
Is Catinazzo Thomas the same person as other filers with this name?
This page covers SEC CIK 1818261 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/catinazzo-thomas-1818261.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.